Further support to the idea of impaired endosomal functioning in AD was observed in the study by Kwart et al. (2019) who created a panel of isogenic knockin human iPSC lines carrying APP and/or PSEN1 mutations. The gene discussed is APP; the disease is Alzheimer disease.